Enbrel, Etanercept

Bookmark

Add to MyYahoo RSS

Enbrel, Etanercept News

News on Enbrel, Etanercept (generic) continually updated from thousands of sources around the net.

Monday Apr 14 | Bloomberg

Chinese Thunder God Herb Works as Well as Pain Therapy

A centuries-old Chinese medical herb known as " thunder god vine " eased the pain and swelling of rheumatoid arthritis as effectively as the commonly prescribed methotrexate, a study showed.

Comment?

Related Topix: Medicine, Health, Pain, Rheumatoid Arthritis, Rheumatrex, Methotrexate (generic), Arthritis

Thu Apr 10, 2014

Pharmaceutical Online

Humira Tops PMLive's 50 Biggest Pharma Brands 2014 List

AbbVie's flagship product Humira retained its top spot in the PMLive Top Pharma List as the biggest pharmaceutical brand for the year 2014.

Comment?

Related Topix: Ulcerative Colitis, Health, Medicine, Arthritis, Rheumatoid Arthritis, Crohn's Disease

Thu Apr 03, 2014

SBWire

New Market Study Published: Advanced in the Rheumatoid Arthritis Market

Rheumatoid arthritis is a chronic disorder for which there is currently no cure.

Comment?

Related Topix: Medicine, Arthritis, Health, Rheumatoid Arthritis, Rheumatology

Wed Apr 02, 2014

The Motley Fool

Biggest Clinical Wins of the Week: Large-Cap Edition

Even great news from the biotechnology giant wasn't enough to avoid the industrywide sell-off last week.

Comment?

Related Topix: Healthcare Law, Law, Medicine, Psoriatic Arthritis, Arthritis, Health, Lung Cancer

Wed Mar 26, 2014

The Motley Fool

Watch Out AbbVie, Here Comes Celgene

Humira's success has attracted a host of new therapies hoping to win away market share, including Johnson & Johnson's ( Otezla, or apremilast, got the FDA go ahead in active psoriatic arthritis patients last week and, in a bid to make Otezla a blockbuster, A new treatment approach Celgene hopes Otezla can continue a string of successful launches ... (more)

Comment?

Related Topix: Medicine, Arthritis, Health, Rheumatoid Arthritis, Psoriatic Arthritis, Pancreatic Cancer, Lung Cancer

Mon Mar 24, 2014

The Motley Fool

Dow Gives up Early Gains as Pfizer Falls; Procter & Gamble, JPMorgan Climb

Yet those gains evaporated quickly, hastened by a drop in the flash Markit Purchasing Managers' Index for March, and as of 10:45 a.m. EDT, the Dow was down 27 points.

Comment?

Related Topix: Procter and Gamble, Household Products, Medicine

Sat Mar 22, 2014

Customer Interaction Solutions

Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of...

Pfizer Inc. announced today detailed results from OPT Compare , a Phase 3 study of tofacitinib, the first in a new class of treatment, oral Janus kinase inhibitors, the safety and efficacy of which are being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

Fri Mar 21, 2014

Bloomberg

Celgene Wins U.S. Approval for Psoriatic Arthritis Pill

Celgene Corp. , the maker of the cancer drug Revlimid, won U.S. approval of a pill to treat psoriatic arthritis that may challenge injections that are among the best-selling drugs on the market.

Comment?

Related Topix: Medicine, Arthritis, Health, Biotech, Celgene, Healthcare Industry, Psoriatic Arthritis, Psoriasis, Food and Drug Administration

AndhraNews

Novartis announces start of new secukinumab (AIN457) versus...

Novartis announces start of new secukinumab versus Stelara phase IIIb head-to-head psoriasis study at AAD 2014 Novartis International AG /Novartis announces start of new secukinumab versus Stelara phase IIIb head-to-head psoriasis study at AAD 2014 .

Comment?

Related Topix: Psoriasis, Medicine, Dermatology

•••
•••
•••
•••
•••
•••
•••
•••